Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 1/2019

01-01-2019 | Original Article

The Polymorphism of SMIM1 Gene in Chinese Dividuals

Authors: Ying Yu, Zhejiong Wang, Linchao Zhu, Yushiang Lin, Haochun Chang, Huaxi Xu

Published in: Indian Journal of Hematology and Blood Transfusion | Issue 1/2019

Login to get access

Abstract

The SMIM1 gene, which encodes the high-frequency blood group antigen Vel, has not been systematically analyzed at the molecular level in Chinese individuals. To better understand the SMIM1 genetic polymorphism, we assessed mutations among healthy Chinese individuals, patients with red blood cell autoantibodies and hematological disease. A total of 130 patients with hematological disease (case I group), 50 patients with red blood cell autoantibodies (case II group), and 500 healthy controls (control group) were enrolled. Exons 3 and 4 in the SMIM1 gene were sequenced to identify genetic variants or mutations. A polyclonal anti-Vel antibody was used to evaluate the expression of the Vel antigenon red blood cells in patients with novel alleles. The novel alleles of the SMIM1 gene were intron 3 position 193 (TT, CT, CC), 194 (GG, AG), 3′ untranslated region positions 81 (CC, CA) and 87 (AA, CA). The single nucleotide polymorphism (SNP) frequencies of intron 3 position 193 TT, CT, CC were 13.1, 39.2, 47.7% in case group I, 6.7, 33.3, 60.0% in case group II and 8.5, 35.6, 56.2% in the control group, respectively. Other minor allele frequencies were all greater than 10% and all SNPs in Chinese showed Vel antigen expression on RBC membranes. The allele at intron 3 position 193 was the most frequent mutant allele found in the Chinese population and Vel antigen deficiency may not cause problems in Chinese patients with hematological diseases and RBC autoantibodies.
Literature
1.
go back to reference Le Masne A, Vachee A, Horbey C et al (1992) Severe form of neonatal hemolytic disease by anti-Vel allo-immunization. Arch Fr Pediatr 49:899–901PubMed Le Masne A, Vachee A, Horbey C et al (1992) Severe form of neonatal hemolytic disease by anti-Vel allo-immunization. Arch Fr Pediatr 49:899–901PubMed
2.
go back to reference Stiller RJ, Lardas O, de Regt RH (1990) Vel isoimmunization in pregnancy. Am J Obstet Gynecol 162:1071–1072CrossRefPubMed Stiller RJ, Lardas O, de Regt RH (1990) Vel isoimmunization in pregnancy. Am J Obstet Gynecol 162:1071–1072CrossRefPubMed
3.
go back to reference Neppert J, Bartz L, Clasen C (1998) Unsatisfactory detection of an in vivo haemolytic anti-vel by the gel test. Vox Sang 75:70–71CrossRefPubMed Neppert J, Bartz L, Clasen C (1998) Unsatisfactory detection of an in vivo haemolytic anti-vel by the gel test. Vox Sang 75:70–71CrossRefPubMed
5.
go back to reference Levine P, Robinson EA, Herrington LB et al (1955) Second example of the antibody for the high-incidence blood factor Vel. Am J Clin Pathol 25:751–754CrossRefPubMed Levine P, Robinson EA, Herrington LB et al (1955) Second example of the antibody for the high-incidence blood factor Vel. Am J Clin Pathol 25:751–754CrossRefPubMed
9.
go back to reference Storry JR, Mallory D (1994) Misidentification of anti-Vel due to inappropriate use of prewarming and adsorption techniques. Immunohematology 10:83–86PubMed Storry JR, Mallory D (1994) Misidentification of anti-Vel due to inappropriate use of prewarming and adsorption techniques. Immunohematology 10:83–86PubMed
10.
go back to reference Cedergren B, Giles CM, Ikin EW (1976) The Vel blood group in northern Sweden. Vox Sang 31:344–355CrossRefPubMed Cedergren B, Giles CM, Ikin EW (1976) The Vel blood group in northern Sweden. Vox Sang 31:344–355CrossRefPubMed
11.
go back to reference Herron R, Hyde RD, Hillier SJ (1979) The second example of an anti-vel auto-antibody. Vox Sang 36:179–181CrossRefPubMed Herron R, Hyde RD, Hillier SJ (1979) The second example of an anti-vel auto-antibody. Vox Sang 36:179–181CrossRefPubMed
12.
go back to reference Gale SA, Rowe GP, Northfield FE (1988) Application of a microtitre plate antiglobulin technique to determine the incidence of donors lacking high frequency antigens. Vox Sang 54:172–173CrossRefPubMed Gale SA, Rowe GP, Northfield FE (1988) Application of a microtitre plate antiglobulin technique to determine the incidence of donors lacking high frequency antigens. Vox Sang 54:172–173CrossRefPubMed
13.
go back to reference Wang CCH, Yue D, Zhu Z (2007) Rare blood group screening in Shanghai China. Lab Med 22:583–584 Wang CCH, Yue D, Zhu Z (2007) Rare blood group screening in Shanghai China. Lab Med 22:583–584
14.
go back to reference Liu T, Liu YML, Zhao F, Zhang R, Shi L (2017) Study on screening for Vel-rare blood type by DNA pooling. Chin J Blood Transfus 30:129–132 Liu T, Liu YML, Zhao F, Zhang R, Shi L (2017) Study on screening for Vel-rare blood type by DNA pooling. Chin J Blood Transfus 30:129–132
15.
go back to reference Wang YGS, Dai J, Lu Y, Wu X, Shen W, Lu Q, Xiang D, Cai X (2015) Multiplex PCR for screening Vel, Sc1, GIL, Inb negative rare blood type. Chin J Blood Transfus 28:1000–1003 Wang YGS, Dai J, Lu Y, Wu X, Shen W, Lu Q, Xiang D, Cai X (2015) Multiplex PCR for screening Vel, Sc1, GIL, Inb negative rare blood type. Chin J Blood Transfus 28:1000–1003
16.
go back to reference Coghlan G, Zelinski T (2016) The c.64_80del SMIM1 allele is segregating in the Hutterite population. Transfusion 56:946–949CrossRefPubMed Coghlan G, Zelinski T (2016) The c.64_80del SMIM1 allele is segregating in the Hutterite population. Transfusion 56:946–949CrossRefPubMed
17.
go back to reference Storry JR, Joud M, Christophersen MK et al (2013) Homozygosity for a null allele of SMIM1 defines the Vel-negative blood group phenotype. Nat Genet 45:537–541CrossRefPubMed Storry JR, Joud M, Christophersen MK et al (2013) Homozygosity for a null allele of SMIM1 defines the Vel-negative blood group phenotype. Nat Genet 45:537–541CrossRefPubMed
18.
go back to reference Dezan MR, Dinardo CL, Bosi SR et al (2016) High-throughput strategy for molecular identification of Vel-blood donors employing nucleic acids extracted from plasma pools used for viral nucleic acid test screening. Transfusion 56:1430–1434CrossRefPubMed Dezan MR, Dinardo CL, Bosi SR et al (2016) High-throughput strategy for molecular identification of Vel-blood donors employing nucleic acids extracted from plasma pools used for viral nucleic acid test screening. Transfusion 56:1430–1434CrossRefPubMed
19.
go back to reference Roback JD, Barclay S, Moulds JM et al (2015) A multicenter study on the performance of a fully automated, walk-away high-throughput analyzer for pretransfusion testing in the US population. Transfusion 55:1522–1528CrossRefPubMed Roback JD, Barclay S, Moulds JM et al (2015) A multicenter study on the performance of a fully automated, walk-away high-throughput analyzer for pretransfusion testing in the US population. Transfusion 55:1522–1528CrossRefPubMed
Metadata
Title
The Polymorphism of SMIM1 Gene in Chinese Dividuals
Authors
Ying Yu
Zhejiong Wang
Linchao Zhu
Yushiang Lin
Haochun Chang
Huaxi Xu
Publication date
01-01-2019
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 1/2019
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-018-0963-8

Other articles of this Issue 1/2019

Indian Journal of Hematology and Blood Transfusion 1/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine